Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials
Open Access
- 1 November 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Therapeutic Innovation & Regulatory Science
- Vol. 48 (6), 671-680
- https://doi.org/10.1177/2168479014554400
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Data-Driven Approach to Risk-Based Source Data VerificationTherapeutic Innovation & Regulatory Science, 2014
- The Value of Source Data Verification in a Cancer Clinical TrialPLOS ONE, 2012
- Accuracy of data transfer: double data entry and estimating levels of errorJournal of Clinical Nursing, 2012
- The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trialClinical Trials, 2011
- Hybrid approaches to clinical trial monitoring: Practical alternatives to 100% source data verificationPerspectives in Clinical Research, 2011
- Risk-Based Source Data Verification Approaches: Pros and ConsDrug Information Journal, 2010
- Quality assurance within the scope of Good Clinical Practice (GCP)—what is the cost of GCP‐related activities? A survey within the Swedish Association of the Pharmaceutical Industry (LIF)'s membersThe Quality Assurance Journal, 2009
- Specific barriers to the conduct of randomized trialsClinical Trials, 2008
- Ensuring trial validity by data quality assurance and diversification of monitoring methodsClinical Trials, 2008
- A Review of the Source Document Verification Process in Clinical TrialsDrug Information Journal, 1999